And a gentle warning that arguing against cost-effectiveness of obesity meds will not age well
And another company says that the IRA is influencing drug-development decisions
And Happy Friday the 13th 👻👻👻
Plus a link to a good piece on prescription drug affordability boards
And a PBM-sponsored survey shows that employers love PBMs
And 'tis the season to think deeply about health insurance
And the Economist has the headline of the week
And Cencora pushes a takedown of ICER's approach to gene therapy
And a useful link on the most important part of the IRA that no one (but you all) has heard of
And I'd love to know whether you're headed to JPM24 and/or want to watch hockey
Plus thinking about the connection between jet fuel and obesity meds
So I can't even get to obesity or copay accumulators until tomorrow